"From evidence to practice" - Insights from the multidisciplinary team on the optimal integration of GLP-1 receptor agonists in obesity management services

被引：1
|
作者：
Brown, Adrian [1 ,2 ,3 ]
Mellor, Duane [4 ,5 ]
Makaronidis, Janine [1 ,2 ,6 ]
Shuttlewood, Emma [7 ]
Miras, Alexander Dimitri [8 ]
Pournaras, Dimitri J. [9 ]
机构：
[1] UCL, Ctr Obes Res, London, England
[2] Univ Coll London Hosp NHS Trust, Bariatr Ctr Weight Management & Metab Surg, London, England
[3] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth & Care Res, London, England
[4] Univ Hosp Leicester NHS Trust, Nutr & Dietet, Leicester, England
[5] Aston Univ, Aston Med Sch, Birmingham, England
[6] Barts Hlth NHS Trust, Royal London Hosp, Dept Diabet & Metab, London, England
[7] Univ Hosp Coventry & Warwickshire NHS Trust, Specialist Weight Management Serv, Coventry, England
[8] Ulster Univ, Sch Nursing, Derry, North Ireland
[9] North Bristol Natl Hlth Serv Trust, Dept Bariatr & Metab Surg, Bristol, England
来源：
NUTRITION BULLETIN | 2024年 / 49卷 / 03期
关键词：
WEIGHT-LOSS MAINTENANCE; DOUBLE-BLIND; 3.0; MG; LIRAGLUTIDE; EFFICACY; PLACEBO; SAFETY; REGAIN; TRIAL;
D O I：
10.1111/nbu.12700
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
引用
收藏
页码：257 / 263
页数：7
相关论文
共 50 条
  • [1] Newer GLP-1 receptor agonists and obesity-diabetes
    Brown, Emily
    Cuthbertson, Daniel J.
    Wilding, John P.
    PEPTIDES, 2018, 100 : 61 - 67
  • [2] Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists
    Goldenberg, Ronald M.
    Gilbert, Jeremy D.
    Manjoo, Priya
    Pedersen, Sue D.
    Woo, Vincent C.
    Lovshin, Julie A.
    OBESITY REVIEWS, 2024, 25 (03)
  • [3] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [4] Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity: A Systematic Review and Meta-Analysis
    Ebrahimi, Pouya
    Batlle, Juan Carlos
    Ayati, Aryan
    Maqsood, M. Haisum
    Long, Clarine
    Tarabanis, Constantine
    Mcgowan, Natalie
    Liebers, David T.
    Laynor, Gregory
    Hosseini, Kaveh
    Heffron, Sean P.
    JAMA PSYCHIATRY, 2025,
  • [5] Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management
    Delrue, Charlotte
    Speeckaert, Marijn M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [6] Obesity and prediabetes. Treatment using GLP-1 receptor agonists
    Ritzel, R. A.
    DIABETOLOGE, 2017, 13 (07): : 482 - 486
  • [7] Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?
    Strong, Jennifer
    Driscoll, Marcia S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (02) : 175 - 182
  • [8] Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice COMMENT
    Wharton, Sean
    Davies, Melanie
    Dicker, Dror
    Lingvay, Ildiko
    Mosenzon, Ofri
    Rubino, Domenica M.
    Pedersen, Sue D.
    POSTGRADUATE MEDICINE, 2022, 134 (01) : 14 - 19
  • [9] Emerging role of GLP-1 receptor agonists in the treatment of obesity
    Neff, Lisa M.
    Kushner, Robert F.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 263 - 273
  • [10] Insulin requirements after switching from GLP-1 receptor agonist to dual GIP/GLP-1 receptor agonist in patients with type 2 diabetes mellitus
    Lahey, Alexa M.
    Duprey, Karolyn
    Montague, Riley C.
    Schadler, Aric D.
    Naseman, Kristina W.
    PHARMACOTHERAPY, 2025, : 220 - 226
12345